Medicines A–Z
C
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 |
Choriogonadotrophin alpha injection | Hospital use only |
|
|
Ciclesonide | Initiation by a respiratory specialist. Supported by a RICaD. |
|
 |
Ciclosporin | ESCA |
|
|
Ciclosporin (Ikervis) | ||
|
Ciclosporin 1mg/ml eye drops, emulsion (Verkazia® ) | Specialist initiation - treatment of severe vernal keratoconjunctivitis (VKC) in children from 4 years of age and adolescents |
|
|
Ciclosporin 2mg/g eye ointment (Optimmune) | ||
|
Ciclosporin capsules (Neoral) | New post transplant |
|
|
Ciclosporin capsules (Neoral) | Post-transplant pre 2013 |
|
|
Ciclosporin concentrate for infusion | ||
|
Ciclosporin intravenous | Hospital only - MHRA specify that oral ciclosporin must be prescribed and dispensed by brand as bioavailability differences exist between brands. |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
